focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Trackwise Designs wins deal; Cake Box names CFO

Fri, 21st Oct 2022 21:29

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

ThinkSmart Ltd - Perth, Australia-based digital payments platform - Says the Federal Court of Australia approved orders for the company to convene a meeting of shareholders to vote on its acquisition by Tuscan Equity Pty Ltd. Expects the scheme meeting to take place through a computershare virtual meeting platform on November 16.

----------

Trackwise Designs PLC - Tewkesbury, Gloucestershire-based products using printed circuit technology - Enters a new agreement for a fixed quantity of flexible printed circuit boards which are due to be delivered through to July 2023 to its unnamed UK EV OEM customer. The new commercial order provides for a GBP4.0 million advanced payment in 2022.

----------

Cake Box Holdings PLC - Wembley, London-based egg-free cream cake seller - Appoints Michael Botha as chief financial officer. He has worked in senior finance and commercial role for the last 20 years.

----------

Globalworth Real Estate Investments Ltd - Investor in real estate in Central and Eastern Europe, with particular focus on Poland and Romania - Says Chief Executive Officer Dimitris Raptis has decided to step down as of December 31. Notes that he will continue to support Globalworth in an advisory role allowing time for a handover period. He joined in 2013 as deputy CEO & Chief Investment Officer and became CEO in 2020.

----------

Corero Network Securities PLC - Amersham, Buckinghamshire-based distributed denial of service cyber defence solutions - Expands its distributed denial of service protection partnership with Juniper Networks, across Juniper's PTX and MX series routers. The extensions prevent DDoS attack traffic and include new enhanced protections against DDoS "carpet bombing".

----------

Trident Royalties PLC - London-based mining royalty and streaming company - Notes Equinox Gold's updated feasibility study for its Los Filos mine complex in Mexico. Explains that the feasibility study contemplates the construction of a carbon-in-leach processing plant beginning in the half of 2023. It outlines peak gold production averaging 360,000 ounces per year to 2030 from 2025, including production in excess of 400,000 ounces in 2025. By comparison, Equinox's latest guidance for 2022 production at Los Filos is 155,000 to 170,000 ounces. Holds an offtake agreement for 50% of all refined gold production up to a cap of 1.1 million ounces from Los Filos. "Equinox continues to deliver on its growth plans with the release of this updated feasibility study, which highlights the tremendous potential at Los Filos. The potential expansion at Los Filos underscores the organic growth within Trident's gold offtakes portfolio," CEO Adam Davidson comments.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Says the required majorities of scheme shareholders voted to approve its acquisition by Neurocrine at a court meeting and general meeting.

----------

Secure Property Development & Investment PLC - London-headquartered commercial property investor focused on southeastern Europe - Chief Executive Officer Lambros Anagnostopoulos buys 1.9 million shares at GBP0.0575 each.

----------

IOG PLC - North Sea-focused gas and infrastructure operator - Chief Executive Officer Rupert Newall purchases 600,000 shares at 9.31 pence per ordinary share.

----------

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
11 May 2020 13:07

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

Read more
15 Apr 2020 14:32

UK TRADING UPDATE SUMMARY: Kromek To Make 2,000 Ventilators For UK

UK TRADING UPDATE SUMMARY: Kromek To Make 2,000 Ventilators For UK

Read more
1 Apr 2020 14:47

Diurnal Gets European Marketing Authorisation For Chronocort

Diurnal Gets European Marketing Authorisation For Chronocort

Read more
6 Mar 2020 17:12

UPDATE: Diurnal Placing Raises GBP11 Million For Drug Development

UPDATE: Diurnal Placing Raises GBP11 Million For Drug Development

Read more
6 Mar 2020 12:40

Diurnal Announces GBP7 Million Placing To Fund Drug Development

Diurnal Announces GBP7 Million Placing To Fund Drug Development

Read more
6 Mar 2020 10:07

Diurnal raises at least ?7m through conditional placing

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced a conditional placing with institutional investors on Friday, to raise at least ?7m before expenses, at a price of 32p per new share.

Read more
5 Mar 2020 17:21

Diurnal Group Names Director Sam Williams Interim Chair

Diurnal Group Names Director Sam Williams Interim Chair

Read more
13 Feb 2020 13:07

Diurnal Says US FDA Accepts New Drug Application For Alkindi Sprinkle

Diurnal Says US FDA Accepts New Drug Application For Alkindi Sprinkle

Read more
13 Feb 2020 09:47

Diurnal clears FDA hurdle for 'Alkindi Sprinkle'

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced on Thursday that its new drug application (NDA) for 'Alkindi', or hydrocortisone granules in capsules for opening and to be known in the US as 'Alkindi Sprinkle', has been accepted for review by the US Food and Drug Administration (FDA).

Read more
11 Feb 2020 13:45

Diurnal narrows loss as it progresses drugs to market

(Sharecast News) - Speciality pharmaceutical company Diurnal Group narrowed its first-half loss by 53% to ?4.6m, it announced on Tuesday, which it said reflected improved revenues and a reduction in clinical development expenses for the period.

Read more
11 Feb 2020 09:20

Diurnal Loss Narrows In First Half Amid Improved Sales Of Alkindi

Diurnal Loss Narrows In First Half Amid Improved Sales Of Alkindi

Read more
4 Feb 2020 15:54

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
20 Jan 2020 11:17

Diurnal In Good Health Ahead Of Second Half Amid Alkindi Progress

Diurnal In Good Health Ahead Of Second Half Amid Alkindi Progress

Read more
16 Dec 2019 13:20

Diurnal Submits Market Authorisation Application For Chronocort

Diurnal Submits Market Authorisation Application For Chronocort

Read more
2 Dec 2019 14:40

Diurnal Submits New Drug Application For Aklindi Sprinkle In US

Diurnal Submits New Drug Application For Aklindi Sprinkle In US

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.